当前位置: 首页 >> 检索结果
21. Fibrotic, metabolic and clinical improvements in patients with chronic hepatitis C treated with direct-acting antiviral therapy in a resource limited setting: a prospective cohort study.
作者: Kinfe Woldu Ekubazgi.;Miftah Dellil.;Beshada Zerfu Woldegeorgis.;Kaleb Assefa Berhane.;Sewale Anagaw.;Henok Fisseha.
来源: BMC Gastroenterol. 2026年 22. A multi-compound dietary supplement to improve the well-being of symptomatic uncomplicated diverticular disease.
作者: Lorenzo Bertani.;Lucia Chico.;Linda Balestrini.;Giulia Della Scala.;Alissa Satriano.;Raffaele Manta.
来源: Minerva Gastroenterol (Torino). 2026年
Current treatment strategies for symptomatic uncomplicated diverticular disease (SUDD) remain controversial. Nutraceuticals could be potential adjuvant treatments to reduce symptoms and improve Quality of Life (QoL).
23. DNA/RNA-Based Next-Generation Sequencing (NGS) Improves the Early Diagnosis and Management of Neoplastic Bile Duct Strictures: A Six-Year, Prospective, Multi-Institutional, Real-Time Study.
作者: Rohit Das.;Jeffrey Kleinberger.;Tarek Sawas.;Abigail I Wald.;Robert Bubar.;Harkirat Singh.;Jennifer Chennat.;Asif Khalid.;Stephanie L Romutis.;Mordechai Rabinovitz.;Anna Tavakkoli.;Kimberly J Fairley.;Brian A Boone.;Savreet Sarkaria.;John Nasr.;Nikhil R Thiruvengadam.;Charles Gabbert.;Sultan Mahmood.;Ahmed A Messallam.;Mihajlo Gjeorgjievski.;Markus Goldschmiedt.;Shyam Thakkar.;Thomas Tielleman.;Mohannad Dugum.;Jon Reich.;Shailendra Singh.;Randall E Brand.;Kevin McGrath.;Kenneth Fasanella.;Anne Marie Lennon.;Rekha Reddy.;Roshan Shrestha.;Daniel J Ellis.;Sara A Singhi.;Terrence Lee.;Peter S Kay.;Ryan D Lee.;Tiffany Y Chua.;Ibrahim Nassour.;James L Buxbaum.;Joanna K Law.;Yasser Bhat.;Prija A Jamidar.;Emily R Jonica.;Jeffrey J Easler.;Wasseem Skef.;Hendrikus Dutch Vanderveldt.;Anil K Dasyam.;David A Geller.;Amer H Zureikat.;Herbert J Zeh.;Patricio M Polanco.;J Wallis Marsh.;Melissa Hogg.;Kenneth K Lee.;James F Pingpank.;M Haroon A Choudry.;Abhinav Humar.;Carl Schmidt.;John Mansour.;Geoffrey Nunns.;Melanie Ongchin.;Alessandro Paniccia.;Sigfred Lajara.;Sara E Monaco.;N Paul Ohori.;Liron Pantanowitz.;James M Mitchell.;Katelyn Smith.;Nuha Shaker.;Anju H Singhi.;Dennis Hsu.;Anwaar Saeed.;Ibrahim H Sahin.;Janie Zhang.;Vikram Gorantla.;John Rhee.;Marina N Nikiforova.;Nisa Kubiliun.;Adam Slivka.;Aatur D Singhi.
来源: Gastroenterology. 2026年
The distinction between benign and neoplastic bile duct strictures remains challenging. Pathologic assessment of ERCP-obtained specimens has limited sensitivity, particularly among patients with primary sclerosing cholangitis (PSC). Next-generation sequencing (NGS) of bile duct specimens provides a promising diagnostic approach; but a prospective, multi-institutional, and comprehensive DNA/RNA analysis is lacking.
25. The Unfinished Agenda in Helicobacter pylori Treatment: Resistance, Microbiome Effects, and Future Directions.
Helicobacter pylori (H. pylori) infection is the principal cause of peptic ulcer disease, MALT lymphoma and non-cardia gastric cancer. The major advances in diagnostics and treatment, eradication success are threatened by rising antimicrobial resistance and concerns about disruption of the normal microbiome. This review summarizes current unresolved issues in H. pylori treatment, with a focus on resistance, optimal regimens, ecological impact, and emerging therapies.
26. Life-threatening lower gastrointestinal bleeding after routine anorectal procedures: a case series and management implications.
This case series characterizes enema- and catheter-induced rectal injuries as an underrecognized iatrogenic cause of life-threatening lower gastrointestinal bleeding (LGIB). By focusing on elderly, high-risk patients, we highlight the diagnostic complexities and management strategies associated with these routine yet potentially catastrophic anorectal procedures.
28. Eradication efficacy of empiric bismuth quadruple therapy containing amoxicillin in the first-line treatment of Helicobacter pylori in Ningxia, China.
作者: Xiaoming Su.;Xianmei Chen.;Yanling Li.;Yuanyuan Tang.;Rui Mu.;Yuting Wu.;Shengjuan Hu.
来源: BMC Gastroenterol. 2026年 30. A Randomized Double-Blind, Placebo-Controlled Dose-Response Study to Assess the Gluten Threshold Dose in Celiac Disease.
作者: A James M Daveson.;Emma Craig.;Alina Vitak.;Robert S Ware.;Jennifer Schafer.;Anuj Sehgal.;Utpal Bose.;Michelle J Colgrave.;Melinda Y Hardy.;Jason A Tye-Din.;Robert P Anderson.
来源: Gastroenterology. 2026年
Celiac disease is an immune-mediated enteropathy triggered by gluten ingestion. The effect of very small gluten exposures remains uncertain, contributing to international variations in food-labelling standards. Interleukin-2 rises rapidly after gluten ingestion serving as a biomarker of immune activation. We aimed to identify the lowest gluten dose that elicits a measurable interleukin-2 response and accompanying symptoms in treated celiac disease.
32. Factors associated with urgent consultation recommendations for patients with inflammatory bowel disease calling a telephone service about worsening symptoms: a secondary analysis.34. Efficacy of swab-based RUT in detecting H. pylori infection: a systematic review and meta-analysis.
作者: Abdelaziz A Awad.;Mohamed A Aldemerdash.;Basma M El-Khalifa.;Ahmed Emara.;Ali M Othman.;Manar A Balouz.;Youssef Narouz.;Doaa A Elmarzouky.;Amira A Albawri.;Yara M Harash.;Ahmed M Zaghloul.;Ahmed Bahnasy.;Ahmed Gad.
来源: BMC Gastroenterol. 2026年 35. 10 year cumulative diagnostic radiation exposure after acute pancreatitis: a retrospective comparison of acute interstitial oedematous and necrotising pancreatitis.
作者: Naomi Ni Chleirigh.;Evan R O'Broin.;Sahil Shet.;Ronan Lee.;Ludolf de Kock.;Eid Kakish.;David J Ryan.;Michael M Maher.
来源: BMC Gastroenterol. 2026年 36. Interpretable stacking model integrating intra-/peritumoral CT-radiomics and serum biomarkers for predicting microvascular invasion in HCC: a dual-center retrospective study.
作者: Fei Wang.;Meng Liu.;Meiheng Liang.;Daowen Zhang.;Xiaolin Tang.;Ming Yang.
来源: BMC Gastroenterol. 2026年 38. Metabolic dysfunction-associated steatohepatitis in the real world: clinical burden, disease progression, and risk stratification with non-invasive tests.
作者: Claudio Sartini.;Ronald Herrera.;Faizan Mazhar.;Zuleika Aponte Torres.;Mireia Raluy.;Mark Yates.;Alia Yousif.;Ramy Younes.;Jörn M Schattenberg.
来源: BMC Gastroenterol. 2026年 |